Deferoxamine Attenuates Lipid Peroxidation, Blocks Interleukin-6 Production, Ameliorates Sepsis Inflammatory Response Syndrome, and Confers Renoprotection After Acute Hepatic Ischemia in Pigs

Artificial Organs

Volumn 36, Issue 4, 2012, Pages 400-408

  Vlahakos, Demetrios ^a   Arkadopoulos, Nikolaos ^a   Kostopanagiotou, Georgia ^a   Siasiakou, Sofia ^a   Kaklamanis, Loukas ^a   Degiannis, Dimitrios ^a   Demonakou, Maria ^a   Smyrniotis, Vassilios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Acute kidney injury; Liver devascularization; Multiorgan failure; Reactive oxygen species

Indexed keywords

ALKALINITY; AMINO ACIDS; BODY FLUIDS; CELL DEATH; FREE RADICALS; LIPIDS; MAMMALS; OXIDATION; OXIDATIVE STRESS; OXYGEN; PHOSPHATASES;

ACUTE KIDNEY INJURY; DEFEROXAMINE; HEPATIC ISCHEMIA; INFLAMMATORY RESPONSE; INTERLEUKIN6 (IL6); LIVER DEVASCULARIZATION; MALONDIALDEHYDE; MULTIORGAN FAILURE; REACTIVE OXYGEN SPECIES; TUBULARS;

AMINES;

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CREATINE KINASE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MALONALDEHYDE; OXYGEN RADICAL; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEPATIC ISCHEMIA; ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERIAL GAS; ARTICLE; BLOOD SAMPLING; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEVASCULARIZATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPOPROTEINEMIA; HYPOTENSION; LEUKOCYTOSIS; LIPID PEROXIDATION; LIVER ISCHEMIA; MULTIPLE ORGAN FAILURE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RENAL PROTECTION; SURGICAL TECHNIQUE; SWINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTOPENIA;

ANIMALIA; SUIDAE;

EID: 84859589503     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01385.x     Document Type: Article

References (37)

1. Levy MM, Fink MP, Marshall JC, etal. 2001 SCCM/ESICM/ACCP/ATS/SIS intrenational sepsis definitions conference. Crit Care Med 2003;31:1250-6.
2. Uchino S, Kellum JA, Bellomo R, etal. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-8.
3. Singh S, Evans TW. Organ dysfunction during sepsis. Intensive Care Med 2006;32:349-60.
4. Aust SD, Morehouse LA, Thomas CE. Role of metals in oxygen radical reactions. Free Radic Biol Med 1985;1:3-25.
5. Davis CL, Kausz AMT, Zager RA, Kharasch ED, Cochran R. Acute renal failure after cardiopulmonary bypass is related to decreased serum ferritin levels. J Am Soc Nephrol 1999;10:2396-402.
6. Ho J, Lucy M, Krokhin O, etal. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. Am J Kidney Dis 2009;53:584-95.
7. Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int 1988;34:474-80.
8. Vulcano M, Meiss RP, Isturiz MA. Deferoxamine reduces tissue injury and lethality in LPS-treated mice. Int J Immunopharmacol 2000;22:635-44.
9. Rose S, Pizanis A, Silomom M. Starch-deferoxamine conjugate inhibits hepatocyte Ca2+ uptake during hemorrhagic shock and resuscitation. J Trauma 2000;49:291-6.
10. Arkadopoulos N, Vlahakos D, Kostopanagiotou G, etal. Iron chelation attenuates intracranial pressure and improves survival in a swine model of acute liver failure. Liver Transpl 2008;14:1116-24.
11. Kostopanagiotou G, Kalimeris K, Arkadopoulos N, etal. Desferrioxamine attenuates minor lung injury following surgical acute liver failure. Eur Respir J 2009;33:1429-36.
12. Paraskevaidis JA, Iliodromitis EK, Vlahakos DV, etal. Deferoxamine infusion during coronary bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance. Eur Heart J 2005;26:263-70.
13. Frühauf NR, Oldhafer KJ, Westermann S, Sotiropoulos GC, Kaiser GM. Acute hepatic failure in swine: hepatectomy versus vascular occlusion. J Invest Surg 2004;17:163-71.
14. Sindrilaru A, Peters T, Wieschalka S, etal. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011;121:985-97.
15. Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 1988;255(Pt 2):F539-44.
16. Ueda N, Baliga R, Shah SV. Role of "catalytic" iron in an animal model of minimal change nephrotic syndrome. Kidney Int 1996;49:370-3.
17. Kays SE, Crowell WA, Johnson MA. Iron supplementation increases gentamycin nephrotoxicity in rats. J Nutr 1991;121:1869-75.
18. Zager RA, Johnson AC, Hanson SY. Parenteral iron therapy exacerbates experimental sepsis. Kidney Int 2004;65:2108-12.
19. Zhou XJ, Laszik Z, Wang XO, Silva FG, Vaziri ND. Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest 2000;80:1905-14.
20. Moch D, Schroppel B, Schoenberg MH, etal. Protective effects of hydroxyethyl starch-deferoxamine in early sepsis. Shock 1995;4:425-32.
21. Ritter C, Andrades M, Reinke A, etal. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med 2004;32:342-9.
22. Messaris E, Antonakis PT, Memos N, etal. Deferoxamine administration in septic animals improved survival and altered apoptotic gene expression. Int Immunopharmacol 2004;4:455-9.
23. Entman ML, Youker K, Shoji T, etal. Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest 1992;90:1335-45.
24. Stamler A, Wang SY, Aguirre DE, Sellke FW, Johnson RG. Effects of pentastarch-deferoxamine conjugate on lung injury after cardiopulmonary bypass. Circulation 1996;94(Suppl.):II358-63.
25. Ritter C, Reinke A, Andrades M, etal. Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats. Crit Care Med 2004;32:2079-83.
26. Lauzon K, Zhao X, Lacasse P. Deferoxamine reduces tissue damage during endotoxin-induced mastitis in dairy cows. J Dairy Sci 2006;89:3846-57.
27. Ateskan U, Mas MR, Yasar M, etal. Deferoxamine and meronem combination therapy in experimental acute pancreatitis. Pancreas 2003;27:247-52.
28. Kruzel ML, Actor JK, Radak Z, etal. Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model. Innate Immun 2010;16:67-79.
29. Menasche P, Pasquier C, Bellucci S, etal. Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 1988;96:582-9.
30. Autenrieth IB, Bohn E, Ewald JH, Heesemann J. Deferoxamine B but not deferoxamine G1 inhibits cytokine production in murine bone marrow macrophages. J Infect Dis 1995;172:490-6.
31. Visseren FL, Verkerk MS, van der Bruggen T, etal. Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumonia or influenza A. Eur J Clin Invest 2002;32(Suppl. 1):84-90.
32. Ono M, Yu B, Hardison EG, Mastrangelo MA, Tweardy DJ. Increased susceptibility to liver injury after hemorrhagic shock in rats chronically fed ethanol: role of nuclear factor-kappa B, interleukin-6 and granulocyte colony-stimulating factor. Shock 2004;21:519-25.
33. Mukaino M, Nakamura M, Yamada O, etal. Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol 2010;224:403-14.
34. Frink M, van Griensven M, Kobbe P, etal. IL-6 predicts organ dysfunction and mortality in patients with multiple injuries. Scand J Trauma Resusc Emerg Med 2009;17:49-55.
35. Cuschieri J, Bulger E, Schaeffer V, etal. Early elevation in random plasma IL-6 after severe injury is associated with development of organ failure. Shock 2010;34:346-51.
36. Huang Z, Wang SR, Su W, Liu JY. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column. Ther Apher Dial 2010;14:596-602.
37. Kielar ML, John R, Bennett M, etal. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 2005;16:3315-25.